Home
/ Adynxx
/ Competitors

Adynxx Competitors and Similar CompaniesClear all

Adynxx's competitors and similar companies include Olpha, Sorrento Therapeutics and ANI Pharmaceuticals.

	Adynxx Adynxx is a biopharmaceutical company focused on bringing to market disease-modifying products for the treatment of pain and inflammation.	Olpha Olpha (formerly known as Olainfarm) is a company engaged in the development and manufacture of pharmaceutical products.	Sorrento Therapeutics Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.	ANI Pharmaceuticals ANI Pharmaceuticals develops, manufactures and markets top quality prescription pharmaceuticals, made in the U.S.A.
Founding Date	Founding Date 2007	Founding Date 1972	Founding Date 2006	Founding Date 1996
Type	Type Public	Type Private	Type Public	Type Public
Tags	Tags Healthcare biotech healthtech pharma	Tags Healthcare drug development pharma	Tags Healthcare biotech healthtech pharma	Tags Healthcare biotech healthtech pharma
Locations	Locations San Francisco, US HQ San Francisco, US	Locations Olaine, LV HQ	Locations San Diego, US HQ San Diego, US	Locations Baudette, US HQ Oakville, CA Baudette, US
Employees	Employees N/A	Employees 2,191	Employees 31019% decrease	Employees 33813% increase
Valuation ($)	Valuation ($) 87.1 k	Valuation ($) N/A	Valuation ($) 1.5 m	Valuation ($) 1.2 b
Financial
Revenue (est.)	Revenue (est.) $2.2m (FY, 2018)	Revenue (est.) €122.2m (FY, 2020)	Revenue (est.) $62.8m (FY, 2022)	Revenue (est.) $883.4m (FY, 2025)
Cost of goods	Cost of goods $1.7m (FY, 2018)	Cost of goods €44.5m (FY, 2020)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit $496k (FY, 2018)	Gross profit €80.1m (FY, 2020)	Gross profit N/A	Gross profit N/A
Net income	Net income ($8.4m) (FY, 2018)	Net income €9.5m (FY, 2020)	Net income ($577.8m) (FY, 2022)	Net income N/A
Funding
Total funding raised	Total funding raised $ 23.5m	Total funding raised N/A	Total funding raised $ 42.6m	Total funding raised N/A